BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.78
0.80%
After-hours: Aug 15, 2025, 06:01 PM EDT

BioLineRx Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
10.44M 4.25M 10.59M 12.99M
Short-Term Investments
9.13M 38.74M 40.49M 44.15M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
3.86M 708K 721K 142K
Inventory
3.15M 1.95M 197.08K 126.73K
Other Current Assets
n/a 480K -197.08K -126.73K
Total Current Assets
27.1M 47.18M 52M 57.4M
Property-Plant & Equipment
1.35M 1.89M 2.5M 2.28M
Goodwill & Intangibles
10.45M 14.85M 21.89M 21.7M
Total Long-Term Assets
11.8M 16.74M 24.38M 23.99M
Total Assets
38.91M 63.92M 76.38M 81.39M
Account Payables
5.58M 10.87M 6.97M 5.57M
Deferred Revenue
n/a 12.96M n/a n/a
Short-Term Debt
4.48M 3.15M 1.54M 2.76M
Other Current Liabilities
2.12M 12.35M 84K 2K
Total Current Liabilities
15.41M 42.78M 10.68M 9.72M
Long-Term Debt
8.96M 6.63M 8.63M n/a
Other Long-Term Liabilities
n/a 11.93M 4.51M 1.86M
Total Long-Term Liabilities
10.04M 19.85M 14.86M 3.58M
Total Liabilities
25.45M 50.7M 25.54M 13.3M
Total Debt
15.04M 11.59M 12.32M 4.65M
Common Stock
38.1M 31.36M 27.1M 21.07M
Retained Earnings
-399.83M -390.61M -329.99M -305.04M
Comprehensive Income
16.13M 16.99M 14.76M 12.72M
Shareholders Equity
13.46M 13.22M 50.84M 68.09M
Total Investments
9.13M 38.74M 40.49M 44.15M